Investigational drugs under study by the United States National Cancer Institute
- 31 March 1976
- journal article
- review article
- Published by Elsevier in Cancer Treatment Reviews
- Vol. 3 (1) , 43-60
- https://doi.org/10.1016/s0305-7372(76)80016-3
Abstract
No abstract availableThis publication has 34 references indexed in Scilit:
- Chemotherapy of CancerAnnual Review of Pharmacology, 1974
- Acute myelocytic leukemia in adultsCancer, 1972
- Chronic toxicity of adriamycin: A new antineoplastic antibioticToxicology and Applied Pharmacology, 1972
- Cross-linking of Complementary Strands of DNA in Mammalian Cells by Antitumour Platinum CompoundsNature, 1972
- Inhibition of Metastatic Spread by I.C.R.F. 159: Selective Deletion of a Malignant CharacteristicBMJ, 1970
- Inhibitory effects of anti‐tumor platinum compounds on DNA, RNA and protein syntheses in mammalian cells in vitroInternational Journal of Cancer, 1970
- Antitumour Activity in a Series of bisDiketopiperazinesNature, 1969
- Toxicity, hæmatological effects and anti-tumour activity of epoxides derived from disubstituted hexitols. Mode of action of mannitol myleran and dibromomannitolEuropean Journal of Cancer (1965), 1968
- The effect of 5-azacytidine on the synthesis of ribosomes in escherichia coliFEBS Letters, 1968
- Inhibition of RNA polymerase reaction by chromomycin A3Biochemical and Biophysical Research Communications, 1965